Product Details for: Inmazeb Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Number | Dosage Form | Route of Administration | Strength | Product Presentation | License Type | Proprietary Name | Marketing Status |
---|---|---|---|---|---|---|---|
001 | Injection | Intravenous | 241.7MG, 241.7MG, 241.7MG/14.5ML (16.67MG, 16.67MG, 16.67MG/ML) | Single-Dose Vial | 351(a) | Inmazeb | Rx |
002 | Injection | Intravenous | 483.3MG, 483.3MG, 483.3MG/14.5ML (33.33MG, 33.33MG, 33.33MG/ML) | Single-Dose Vial | 351(a) | Inmazeb | Rx |
Proper Name
atoltivimab, maftivimab, and odesivimab-ebgn
BLA Number
761169
Applicant
Regeneron Pharmaceuticals, Inc.
Original Approval Date
October 14, 2020
Date of First Licensure